DRUG REPURPOSING

Clinical trials for DRUG REPURPOSING explained in plain language.

Never miss a new study

Get alerted when new DRUG REPURPOSING trials appear

Sign up with your email to follow new studies for DRUG REPURPOSING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New triple therapy aims to outsmart drug-resistant liver cancer

Disease control Not yet recruiting

This study tests a three-drug combination (ivarmacitinib, camrelizumab, and apatinib) in 65 adults with advanced liver cancer that initially responded to immunotherapy but then stopped working. The goal is to see if adding a JAK inhibitor can re-sensitize the tumor to immune atta…

Matched conditions: DRUG REPURPOSING

Phase: PHASE2 • Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Disease control

Last updated May 26, 2026 09:33 UTC

DRUG REPURPOSING

Get alerted when new DRUG REPURPOSING trials appear

New triple therapy aims to outsmart drug-resistant liver cancer